QA: Nanoviricides INC in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001379006_2019_Nanoviricides_INC.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001379006, Nanoviricides INC

  xvar xval
0 AssetsCurrent 7,322,028
1 IntangibleAssetsNetIncludingGoodwill 374,929
2 PropertyPlantAndEquipmentNet 10,841,093
3 remainder_Assets 8,162
4 LiabilitiesCurrent 881,948
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 3,485,642
9 ResearchAndDevelopmentExpense 5,883,931
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 172,460
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 18,546,212
1 Liabilities 881,948
2 Expenses 9,369,573
3 Revenues 0
4 StockholdersEquity 17,664,264
5 NetIncome -9,197,113
6 ComprehensiveNetIncome -9,197,113
7 BaseVar 14,485,096
8 EconomicCapitalRatiobeforeLimitedLiability 3.02
9 EconomicCapitalRatio 3.70

Edgar->Model Mapping

Feature Distribution

Change over Time